A K Boggild1,2,3, M Libman4, C Greenaway5, A E McCarthy6. 1. Tropical Disease Unit, Toronto General Hospital, University Health Network, Toronto, ON. 2. Department of Medicine, University of Toronto, Toronto, ON. 3. Public Health Ontario Laboratories, Toronto, ON. 4. J. D. MacLean Centre for Tropical Disease, Division of Infectious Disease, Department of Microbiology, McGill University Health Centre, Montréal, QC. 5. Jewish General Hospital, Division of Infectious Diseases, Centre for Clinical Epidemiology, Lady Davis Institute for Medical Research, McGill University, Montréal, QC. 6. Tropical Medicine and International Health Clinic, Division of Infectious Disease, Ottawa Hospital General Campus, Ottawa, ON.
Abstract
BACKGROUND: Strongyloides stercoralis is a parasitic nematode found in humans, with a higher prevalence in tropical and sub-tropical regions worldwide. If untreated, the infection can progress to disseminated strongyloidiasis, a critical illness which may be fatal. OBJECTIVE: To provide clinical guidance on the prevention, assessment and management of disseminated strongyloidiasis. METHODS: A literature review was conducted to evaluate the current evidence and to identify any systematic reviews, case reports, guidelines and peer reviewed and non-peer reviewed medical literature. The Committee to Advise on Tropical Medicine and Travel (CATMAT) assembled a working group to develop this statement, which was then critically reviewed and approved by all CATMAT members. RECOMMENDATIONS: CATMAT recommends that screening for strongyloidiasis should be considered for individuals with epidemiologic risk and/or co-morbidities that place them at risk for Strongyloides hyperinfection and dissemination. Those at highest risk of hyperinfection and dissemination are individuals born in a Strongyloides-endemic area who undergo iatrogenic immunosuppression or have intercurrent human T-lymphotropic virus (HTLV-1) infection. Diagnosis of strongyloidiasis is based on serologic testing and/or examination of stools and other clinical specimens for larvae. Referral to a tropical medicine specialist with expertise in the management of strongyloidiasis is recommended for suspected and confirmed cases. A diagnosis and treatment algorithm for strongyloidiasis has been developed as a reference tool. CONCLUSION: Strongyloidiasis is relatively widespread in the global migrant population and screening for the disease should be based on an individual risk assessment. A practical tool for the clinician to use in the prevention, assessment and management of disseminated strongyloidiasis in Canada is now available.
BACKGROUND: Strongyloides stercoralis is a parasitic nematode found in humans, with a higher prevalence in tropical and sub-tropical regions worldwide. If untreated, the infection can progress to disseminated strongyloidiasis, a critical illness which may be fatal. OBJECTIVE: To provide clinical guidance on the prevention, assessment and management of disseminated strongyloidiasis. METHODS: A literature review was conducted to evaluate the current evidence and to identify any systematic reviews, case reports, guidelines and peer reviewed and non-peer reviewed medical literature. The Committee to Advise on Tropical Medicine and Travel (CATMAT) assembled a working group to develop this statement, which was then critically reviewed and approved by all CATMAT members. RECOMMENDATIONS: CATMAT recommends that screening for strongyloidiasis should be considered for individuals with epidemiologic risk and/or co-morbidities that place them at risk for Strongyloides hyperinfection and dissemination. Those at highest risk of hyperinfection and dissemination are individuals born in a Strongyloides-endemic area who undergo iatrogenic immunosuppression or have intercurrent human T-lymphotropic virus (HTLV-1) infection. Diagnosis of strongyloidiasis is based on serologic testing and/or examination of stools and other clinical specimens for larvae. Referral to a tropical medicine specialist with expertise in the management of strongyloidiasis is recommended for suspected and confirmed cases. A diagnosis and treatment algorithm for strongyloidiasis has been developed as a reference tool. CONCLUSION: Strongyloidiasis is relatively widespread in the global migrant population and screening for the disease should be based on an individual risk assessment. A practical tool for the clinician to use in the prevention, assessment and management of disseminated strongyloidiasis in Canada is now available.
Authors: A K Boggild; J Geduld; M Libman; B J Ward; A McCarthy; J Hajek; W Ghesquiere; J Vincelette; S Kuhn; D O Freedman; K C Kain Journal: Can Commun Dis Rep Date: 2014-09-18
Authors: Mara Waters; Sigmund Krajden; Christie Kim; Reem Elsobky; Bohdan Lychacz; Matthew Cheung; Mark Crowther; Jay Keystone Journal: Am J Trop Med Hyg Date: 2019-08 Impact factor: 2.345
Authors: Samuel De l'Étoile-Morel; Faheel Naeem; Mohammad Alghounaim; Makeda Semret; Cedric P Yansouni; Michael D Libman; Sapha Barkati Journal: Am J Trop Med Hyg Date: 2022-07-05 Impact factor: 3.707
Authors: Jennifer Tam; Kevin L Schwartz; Jay Keystone; Dimitri Dimitrakoudis; Mark Downing; Sigmund Krajden Journal: Am J Trop Med Hyg Date: 2019-01 Impact factor: 2.345
Authors: Larissa R Bosqui; Priscilla D Marques; Gessica B de Melo; Maria do Rosário F Gonçalves-Pires; Fernanda M Malta; Wander R Pavanelli; Ivete Conchon-Costa; Julia M Costa-Cruz; Fabiana M Paula; Idessania N Costa Journal: Mol Diagn Ther Date: 2018-08 Impact factor: 4.074
Authors: Carl Boodman; Yashpal S Chhonker; Daryl J Murry; Allison Mah; Jennifer Grant; Theodore Steiner; Michael Libman; Cesilia Nishi; Marthe Charles Journal: Am J Trop Med Hyg Date: 2018-11 Impact factor: 2.345
Authors: Sabrina H M Yeung; Omar Mourad; Michael Klowak; Adrienne J Showler; Stefanie Klowak; Andrea K Boggild Journal: Trop Dis Travel Med Vaccines Date: 2019-04-03